135 related articles for article (PubMed ID: 19722894)
1. Prospects for developing an effective particle-mediated DNA vaccine against influenza.
Yager EJ; Dean HJ; Fuller DH
Expert Rev Vaccines; 2009 Sep; 8(9):1205-20. PubMed ID: 19722894
[TBL] [Abstract][Full Text] [Related]
2. Epidermal DNA vaccine for influenza is immunogenic in humans.
Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
[TBL] [Abstract][Full Text] [Related]
3. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
4. DNA-based influenza vaccines as immunoprophylactic agents toward universality.
Zhang H; El Zowalaty ME
Future Microbiol; 2016; 11(1):153-64. PubMed ID: 26673424
[TBL] [Abstract][Full Text] [Related]
5. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
6. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.
Wang S; Zhang C; Zhang L; Li J; Huang Z; Lu S
Vaccine; 2008 Apr; 26(17):2100-10. PubMed ID: 18378365
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.
Loudon PT; Yager EJ; Lynch DT; Narendran A; Stagnar C; Franchini AM; Fuller JT; White PA; Nyuandi J; Wiley CA; Murphey-Corb M; Fuller DH
PLoS One; 2010 Jun; 5(6):e11021. PubMed ID: 20544035
[TBL] [Abstract][Full Text] [Related]
8. Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferrets.
Yager EJ; Stagnar C; Gopalakrishnan R; Fuller JT; Fuller DH
Methods Mol Biol; 2013; 940():223-37. PubMed ID: 23104347
[TBL] [Abstract][Full Text] [Related]
9. Potential advantages of DNA immunization for influenza epidemic and pandemic planning.
Webster RG
Clin Infect Dis; 1999 Feb; 28(2):225-9. PubMed ID: 10064231
[TBL] [Abstract][Full Text] [Related]
10. Influenza Plasmid DNA Vaccines: Progress and Prospects.
Bicho D; Queiroz JA; Tomaz CT
Curr Gene Ther; 2015; 15(6):541-9. PubMed ID: 26415574
[TBL] [Abstract][Full Text] [Related]
11. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
Dégano P; Schneider J; Hannan CM; Gilbert SC; Hill AV
Vaccine; 1999 Nov; 18(7-8):623-32. PubMed ID: 10547421
[TBL] [Abstract][Full Text] [Related]
12. Effective construction of DNA vaccines against variable influenza genes by homologous recombination.
Ljungberg K; Wahren B; Almqvist J; Hinkula J; Linde A; Winberg G
Virology; 2000 Mar; 268(2):244-50. PubMed ID: 10704333
[TBL] [Abstract][Full Text] [Related]
13. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
van Doorn E; Pleguezuelos O; Liu H; Fernandez A; Bannister R; Stoloff G; Oftung F; Norley S; Huckriede A; Frijlink HW; Hak E
BMC Infect Dis; 2017 Apr; 17(1):241. PubMed ID: 28376743
[TBL] [Abstract][Full Text] [Related]
15. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
Grødeland G; Bogen B
Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
17. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.
Huber VC; Thomas PG; McCullers JA
Vaccine; 2009 Feb; 27(8):1192-200. PubMed ID: 19135117
[TBL] [Abstract][Full Text] [Related]
18. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
19. Protection against influenza B virus infection by immunization with DNA vaccines.
Chen Z; Kadowaki S; Hagiwara Y; Yoshikawa T; Sata T; Kurata T; Tamura S
Vaccine; 2001 Jan; 19(11-12):1446-55. PubMed ID: 11163667
[TBL] [Abstract][Full Text] [Related]
20. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
Choo AY; Broderick KE; Kim JJ; Sardesai NY
IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
